secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lifeloc Technologies, Inc (LCTC)
CIK:        0001493137
Form:       8-K
Filed at:   2023-08-07T23:59:59+00:00
Accession:  0001079973-23-001070
Event type: earnings
Sentiment:  positive
Materiality: 0.70
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lifeloc Q2 2023 net profit $55K vs loss last year; SpinDx beta testing expected in 2023
--------------------------------------------------------------------------------

- Quarterly revenue $2.280M, up 5% YoY; net profit $55K ($0.02 diluted EPS) vs loss of $(202)K in Q2 2022.
- Gross margin improved to 45.7% from 30.4% YoY on price increases, lower depreciation, and easing supply constraints.
- R&D spending rising for SpinDx platform; beta testing of saliva THC detection device expected in 2023, commercialization in 2024.
- CEO notes production backlog partially satisfied; supply constraints no longer a significant impediment to order flow.
- Six-month net profit $1K (breakeven) vs loss of $(346)K in same period of 2022.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1493137/000107997323001070/0001079973-23-001070-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1493137/000107997323001070/lctc_8k.htm
  HTML page:      https://secwatch.observer/filing/0001079973-23-001070

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer